Northwest Biotherapeutics (LTS:0K95) Market Cap : £418.80 Mil (As of May. 26, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Northwest Biotherapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Northwest Biotherapeutics's share price for the quarter that ended in Mar. 2024 was £2.4. Northwest Biotherapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 1,195.36 Mil. Therefore, Northwest Biotherapeutics's market cap for the quarter that ended in Mar. 2024 was £2,868.86 Mil.

Northwest Biotherapeutics's quarterly market cap increased from Sep. 2023 (£2,748.19 Mil) to Dec. 2023 (£2,821.10 Mil) and increased from Dec. 2023 (£2,821.10 Mil) to Mar. 2024 (£2,868.86 Mil).

Northwest Biotherapeutics's annual market cap increased from Dec. 2021 (£2,276.16 Mil) to Dec. 2022 (£2,564.16 Mil) and increased from Dec. 2022 (£2,564.16 Mil) to Dec. 2023 (£2,821.10 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Northwest Biotherapeutics's Enterprise Value for Today is £455.51 Mil.

Northwest Biotherapeutics Market Cap Historical Data

The historical data trend for Northwest Biotherapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Northwest Biotherapeutics Market Cap Chart

Northwest Biotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

1,474.32

1,991.04

2,276.16

2,564.16

2,821.10

Northwest Biotherapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															2,599.44	2,676.48	2,748.19	2,821.10	2,868.86

Competitive Comparison of Northwest Biotherapeutics's Market Cap

For the Biotechnology subindustry, Northwest Biotherapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Northwest Biotherapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Northwest Biotherapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Northwest Biotherapeutics's Market Cap falls into.

Northwest Biotherapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Northwest Biotherapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	£2.4	*	1175.46
	=	£2,821.10

Northwest Biotherapeutics's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	£2.4	*	1195.36
	=	£2,868.86

Northwest Biotherapeutics (LTS:0K95) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Northwest Biotherapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Northwest Biotherapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Northwest Biotherapeutics (LTS:0K95) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Northwest Biotherapeutics Inc (LTS:0K95) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

NWBO:USA NBYB:Germany

Address

4800 Montgomery Lane, Suite 800, Bethesda, MD, USA, 20814

Website

https://www.nwbio.com

Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S. Food and Drug Administration.

Northwest Biotherapeutics (LTS:0K95) Headlines

No Headlines